Azor and Antivert drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 3 people who take Azor and Antivert. Common interactions include acute myocardial infarction among females.

The phase IV clinical study analyzes what interactions people who take Azor and Antivert have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

3 people who take Azor and Antivert together, and have interactions are studied.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is used in high blood pressure. Currently, eHealthMe is studying from 3,895 Azor users.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is used in dizziness. Currently, eHealthMe is studying from 4,028 Antivert users.

Number of Azor and Antivert reports submitted per year:

Common Azor and Antivert drug interactions by gender *:

female:

Acute myocardial infarction
Anaemia
Dysuria
Ear disorder
Epigastric discomfort
Fall
Femur fracture
Fibrocystic breast disease
Flushing
General symptom

male:

n/a

Common Azor and Antivert drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Flushing
Generalised erythema
Skin burning sensation
Skin discolouration

60+:

Acute myocardial infarction
Anaemia
Dysuria
Ear disorder
Epigastric discomfort
Fall
Femur fracture
Fibrocystic breast disease
General symptom
Haemangioma

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Antivert?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .

Related studies

Drug side effects by duration, gender and age:

Azor side effects (3,895 reports)
Antivert side effects (4,028 reports)

Common Azor drug interactions:

Azor and Benicar: 813 reports
Azor and Aspirin: 543 reports
Azor and Benicar hct: 447 reports
Azor and Metformin: 272 reports
Azor and Nexium: 266 reports
Azor and Tribenzor: 225 reports
Azor and Amlodipine: 220 reports
Azor and Lipitor: 216 reports
Azor and Crestor: 209 reports
Azor and Prednisone: 190 reports

Browse interactions between Azor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Antivert drug interactions:

Antivert and Aspirin: 748 reports
Antivert and Lasix: 581 reports
Antivert and Synthroid: 567 reports
Antivert and Prilosec: 512 reports
Antivert and Xanax: 466 reports
Antivert and Nexium: 438 reports
Antivert and Tylenol: 413 reports
Antivert and Lipitor: 410 reports
Antivert and Neurontin: 401 reports
Antivert and Prednisone: 382 reports

Browse interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil and meclizine hydrochloride (the active ingredients of Azor and Antivert, respectively), and Azor and Antivert (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Azor and Antivert.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Nuedexta and Buspar drug interaction - 6 seconds ago
Oncovin and Wellbutrin Xl drug interaction - 7 seconds ago
Fosamax and Namzaric drug interaction - 8 seconds ago
Leuprolide Acetate and Pergonal drug interaction - 20 seconds ago
Tylenol and Butrans drug interaction - 25 seconds ago
Luvox and Pimozide drug interaction - 26 seconds ago
Zolpidem and Incruse Ellipta drug interaction - 47 seconds ago
Antivert and Eskalith Cr drug interaction - 51 seconds ago
Multihance and Systemic Sclerosis (Scleroderma) - a minute ago
Omeprazole and Cystoid Macular Oedema - a minute ago